Published in BMC Musculoskelet Disord on December 27, 2007
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis. Oncogene (2009) 1.10
Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling. Am J Physiol Cell Physiol (2011) 0.95
Validation of adequate endogenous reference genes for the normalisation of qPCR gene expression data in human post mortem tissue. Int J Legal Med (2010) 0.93
Delivery of siRNA silencing Runx2 using a multifunctional polymer-lipid nanoparticle inhibits osteogenesis in a cell culture model of heterotopic ossification. Integr Biol (Camb) (2012) 0.88
Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study. Clin Orthop Relat Res (2009) 0.87
The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatin. J Bone Miner Metab (2012) 0.81
Periarticular bone loss in antigen-induced arthritis. Arthritis Rheum (2013) 0.79
Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41
Bone morphogenetic proteins. Growth Factors (2004) 8.61
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature (2006) 7.69
Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev (2000) 2.68
Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest (2002) 2.59
Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther (2004) 2.55
BMP signaling in skeletal development. Biochem Biophys Res Commun (2005) 2.13
Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology (2000) 2.13
The disparate role of BMP in stem cell biology. Oncogene (2005) 1.92
The BMP signaling and in vivo bone formation. Gene (2005) 1.82
Bone morphogenetic proteins: from basic studies to clinical approaches. Bone (1998) 1.69
Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol (2000) 1.62
Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci (1999) 1.61
The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol (2003) 1.61
Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. J Invest Dermatol (2003) 1.60
Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. J Biol Chem (2005) 1.47
Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol Chem (2004) 1.47
Dentin regeneration by dental pulp stem cell therapy with recombinant human bone morphogenetic protein 2. J Dent Res (2004) 1.46
Expression of bone morphogenetic proteins during mandibular distraction osteogenesis in rabbits. J Oral Maxillofac Surg (2003) 1.45
Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician? J Oral Sci (2003) 1.34
Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells (2004) 1.23
Expression of bone morphogenetic proteins and Msx genes during root formation. J Dent Res (2003) 1.22
Mechanical tension-stress induces expression of bone morphogenetic protein (BMP)-2 and BMP-4, but not BMP-6, BMP-7, and GDF-5 mRNA, during distraction osteogenesis. J Bone Miner Res (1999) 1.18
Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN. Arthritis Res (2000) 1.16
Gene therapy for bone regeneration. Curr Gene Ther (2005) 1.13
Long-term outcomes in open pelvic fractures. J Trauma (1997) 1.07
Use of bone morphogenetic proteins in traumatology. Injury (2005) 1.05
Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone (2000) 1.00
Expression of bone morphogenetic proteins in salivary pleomorphic adenomas. Virchows Arch (1998) 0.99
Medium- and long-term results of open reduction and internal fixation for unstable pelvic ring fractures. Orthopedics (2000) 0.98
Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J Gene Med (2004) 0.92
Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J Clin Invest (1998) 0.92
Evaluation of male sexual function after pelvic trauma by the International Index of Erectile Function. Urology (2000) 0.89
The role of bone morphogenetic proteins BMP-2 and BMP-4 and their related postreceptor signaling system (Smads) in distraction osteogenesis of the mandible. J Craniofac Surg (2004) 0.89
Discovery and development of BMPs. Injury (2005) 0.89
Expression of bone morphogenetic proteins in normal human intramembranous and endochondral bones. Int J Oral Maxillofac Surg (2006) 0.87
Bone morphogenetic protein in spinal fusion: overview and clinical update. Neurosurg Focus (2001) 0.78
Osteogenic properties of various HeLa cell lines and the BMP family genes expression. Ann Transplant (2002) 0.77
Survival and success rates of autotransplanted premolars: a prospective study of the protocol for developing teeth. Am J Orthod Dentofacial Orthop (2013) 1.06
Endometrial morphology and pituitary-gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis--a multicentre study. Nephrol Dial Transplant (2004) 0.88
Comparison of efficiency of platelet rich plasma, hematopoieic stem cells and bone marrow in augmentation of mandibular bone defects. N Y State Dent J (2007) 0.84
[Occurrence of oral subclinical infections in insulin treated diabetics]. Wiad Parazytol (2004) 0.83
Estimation of the specific surface area of apatites in human mineralized tissues using 31P MAS NMR. Solid State Nucl Magn Reson (2007) 0.82
Influence of fluvastatin on bone formation induced by demineralized bone matrix in mice. Pharmacol Rep (2006) 0.82
Is implanto-prosthodontic treatment available for haemodialysis patients? Nephrol Dial Transplant (2007) 0.81
Fractal and Fourier analysis of the hepatic sinusoidal network in normal and cirrhotic rat liver. J Anat (2005) 0.81
Symmetry of retinal vessel arborisation in normal and amblyopic eyes. Ophthalmologica (2009) 0.80
Effects of old age on vascular complexity and dispersion of the hepatic sinusoidal network. Microcirculation (2008) 0.78
BMP-4 and BMP-6 involvement in the osteogenic properties of the HeLa cell line. Exp Biol Med (Maywood) (2002) 0.78
Fluvastatin increases tyrosinase synthesis induced by UVB irradiation of B16F10 melanoma cells. Folia Histochem Cytobiol (2009) 0.77
Fluvastatin increases tyrosinase synthesis induced by alpha-melanocyte-stimulating hormone in B16F10 melanoma cells. Pharmacol Rep (2010) 0.77
New factors affecting bone remodeling. Ortop Traumatol Rehabil (2004) 0.76
Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease. Clin Chem Lab Med (2003) 0.76
[Menstrual disturbances and alternations in hypophyseal gonadal axis in end-stage premenopausal women undergoing hemodialysis: a multi-center study]. Pol Arch Med Wewn (2003) 0.76
Fluvastatin influences hair color in C57BL/6 mice. Int J Mol Sci (2013) 0.75
Aggressive osteoblastoma of the sphenoid bone. Oncol Lett (2010) 0.75
[Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism]. Pol Arch Med Wewn (2004) 0.75
Influence of osteoprotegerin (OPG) on resorption of heterotopically induced ossicle. Cell Tissue Bank (2004) 0.75
Cross-linked C-terminal telopeptide of type I collagen in serum before and after treatment with alfacalcidol and calcium carbonate in early and moderate chronic renal failure. Nephron (2002) 0.75
[Statins and their pleiotropic effects]. Pol Merkur Lekarski (2008) 0.75
[The importance of lactoferrin in bone regeneration]. Pol Merkur Lekarski (2014) 0.75
[Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis]. Pol Arch Med Wewn (2003) 0.75
Influence of osteoprotegerin (OPG) on experimentally induced ectopic bone. Folia Biol (Krakow) (2004) 0.75
[Cytokeratin detection as a diagnostic tool in oncology]. Pol Merkur Lekarski (2007) 0.75
Human mucosal epithelium involvement in prenatal growth of maxillary sinuses. Ital J Anat Embryol (2003) 0.75
[Dental cardio common position for dealing anticoagulation in patients undergoing dental procedures]. Kardiol Pol (2016) 0.75
[The evaluation of mineral crystallinity of mandibular bone tissue using electron paramagnetic resonance (EPR) in patients suffering from renal osteodystrophy]. Przegl Lek (2006) 0.75
Recurrent Pyogenic Granuloma Around Dental Implants: A Rare Case Report. Int J Periodontics Restorative Dent (2016) 0.75
[Factors affecting melanogenesis and methods used for identification of pigmentation disorders]. Pol Merkur Lekarski (2008) 0.75
Menopausal status strongly influences the utility of predictive models in differential diagnosis of ovarian tumors: an external validation of selected diagnostic tools. Ginekol Pol (2014) 0.75
Osteoinductive properties of urothelium depend on inherent bone morphogenetic proteins (BMPs). Med Sci Monit (2005) 0.75
Immediate Palatal Molar Implants: A Simple, Safe, Minimally Invasive Technique. Int J Periodontics Restorative Dent (2017) 0.75